+
Cookie settings
Mandatory
Mandatory cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookie.
Functional
Functional cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in. Functional cookies are currently unused.
Statistical
Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. Statistical cookies are currently unused.
Marketing
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers. Marketing cookies are currently unused.

About us

LT Biotech was founded in 2009 and has extensive experience in both upstream and downstream products and services. The company offers a comprehensive portfolio of over 250 products for cell culture, protein purification, and diagnostics, including various cell culture media, sera, and other additives for cell growth, as well as chromatography resins for protein purification and rapid veterinary and human diagnostic testing systems. Our deep expertise enables us to deliver reliable, high-quality, and cost-effective solutions for universities, research laboratories, and small- to mid-sized biotech and pharmaceutical manufacturers.

LT Biotech is headquartered in Vilnius, Lithuania, at the Visoriai High-Tech Park, a dynamic hub for pharma, biotech, medical, solar, and space satellite electronics, and other advanced technology companies. We collaborate closely with the BOD Group, operating from some of the most environmentally friendly manufacturing buildings in Europe: the Innovation and Business Centre (IBC) and Lithuania’s incubator for green and high technologies (LIGHT), both located on Mokslininku (Scientists) Street, at numbers 2 and 6A respectively. These facilities are nearly 100% CO₂ neutral, with hundreds of geothermal wells, solar panels on the roof and facade, and smart energy storage systems, highlighting our commitment to sustainability while maintaining cutting-edge biotech production capabilities [1].

Lithuania stands at the forefront of biotechnology innovation. The country is 1st in the European Union for the proportion of secondary education graduates, with 25% of students pursuing life science programs. Lithuania ranks 3rd globally (among all OECD countries) for biotech R&D intensity, and 92%of its life sciences products are exported to over100 countries. This environment of innovation, education, and international reach enables us to provide world-class biotechnological solutions [2].